Top 100 U.S. law firm Akerman LLP today announced the growth of its national Healthcare Practice Group with partner Noam Fischman in Washington, D.C. He joins from Polsinelli where he served as chair of its Mergers & Acquisitions Litigation Working Group, a taskforce dedicated to deal-related litigation.
Healthcare Practice Group Chair Robert Slavkin said, “Noam is a subject matter expert in M&A litigation and False Claims Act defense for healthcare clients. These are areas in which our clients frequently turn to Akerman for assistance, and Noam’s arrival bolsters our capabilities to provide them with exceptional legal counsel across the United States.”
An experienced healthcare litigator and go-to trial lawyer, Fischman is a trusted guide for healthcare providers, pharmaceutical companies, life sciences companies, and related healthcare vendors, leading clients through cases in federal and state courts, as well as government investigations and matters involving regulatory agencies. Fischman has a specific focus on managing risk related to fraud and alleged false claims, and fiduciary duty-related issues for hospitals and hospital systems, behavioral health centers, ambulance companies, and skilled nursing facilities. Additionally, Fischman has focused a significant portion of his practice to managing deal-related due diligence for clients engaging in corporate mergers and other transformational transactions, and advising clients about – and litigating when necessary – post-closing deal disputes.
Outside of the healthcare industry, for more than twenty years, Fischman has managed commercial litigation needs for clients ranging from contract disputes to commercial fraud matters to challenges to government action under the Administrative Procedure Act, among other types of cases. Fischman routinely advises clients on issues related to the Foreign Corrupt Practices Act and manages related due diligence and investigations. He has litigated RICO matters and has guided clients through employment-related litigation and litigation issues associated with the EB-5 foreign investor program. He has also served for years in the role of outside general counsel and has advised several Boards of Directors on matters related to corporate and non-profit governance.
